Many Investors Still Treating Gilead: 4 Launches This Year Could Prove Them Wrong
Gilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
Choosing a Traditional IRA can provide tax benefits and help secure your retirement. Discover how it fits into your financial strategy.
21,434 articlesGilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
Markets react to health headlines and policy shifts as investors reassess exposure to healthcare, insurance, and biot...
A top Sea Limited executive sold a sizable stake, triggering questions about the stock's future. This guide breaks do...
A routine call turned into a financial nightmare when a fraudster impersonated Chase Bank, guiding a victim to transf...
A triple-leveraged ETF focused on semiconductors can swing wildly. This piece breaks down why the direxion daily semi...
When a board member sells 7,000 shares, traders and long-term investors want to know why. This article breaks down Fo...
Microsoft CEO Satya Nadella charts a pragmatic path for enterprise AI: keep data within your own boundary, govern wit...
Today’s jump in the super micro computer stock surprised many, even as revenue guidance cooled. This article breaks d...
A large new stake underscores Core Scientific's shift toward data center services. This article breaks down the impli...
AppLovin reported its best quarter in history, with record revenue and an 84% EBITDA margin, but the stock declined s...
A single quarterly filing can rewrite a fund’s star players. Tepper’s Appaloosa appears to have shifted away from NVI...
XRP is facing renewed selling pressure across major trading pairs, with a looming test of the $1.20 support and criti...